Benadryl

DRUG5 trials

Conditions

Advanced Solid TumorBreast CancerChronic PainHeadacheIntranasal KetamineKidney CancerMetastatic Castration-resistant Prostate CancerNon-metastatic Castration-resistant Prostate Cancer

Phase 1

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

CompletedNCT03493945

National Cancer Institute (NCI)Advanced Solid Tumor, Metastatic Castration-resistant Prostate Cancer, Non-metastatic Castration-resistant Prostate Cancer +3

Start: 2018-05-01End: 2024-10-08Updated: 2025-09-30

Phase 2

TPI 287 in Breast Cancer Metastatic to the Brain

CompletedNCT01332630

M.D. Anderson Cancer CenterBreast Cancer

Start: 2011-08-16End: 2017-04-14Updated: 2018-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

CompletedNCT01392183

M.D. Anderson Cancer CenterKidney Cancer

Start: 2012-10-24End: 2019-09-08Updated: 2021-09-20

Phase 3

THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department

CompletedNCT03081416

Brooke Army Medical CenterHeadache, Intranasal Ketamine

Start: 2016-05-31End: 2017-10-31Updated: 2018-01-18

Unknown Phase

Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics

TerminatedNCT00505531

Massachusetts General HospitalChronic Pain

Start: 2007-06-30End: 2007-12-31Updated: 2020-07-22

Cancer Immunology Research2026-02-18

582 Immune correlates from QuEST1 in men with castration-resistant prostate cancer

Regular and Young Investigator Award Abstracts2021-11-012 citations

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer2021-09-0136 citations

Phase I trial of a modified vaccinia ankara (MVA) priming vaccine followed by a fowlpox virus (FPV) boosting vaccine modified to express brachyury and costimulatory molecules in advanced solid tumors.

Journal of Clinical Oncology2019-05-20

Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

Journal for ImmunoTherapy of Cancer2018-09-1858 citations

A randomized phase II trial of pazopanib (PAZ) vs. temsirolimus (TEM) in patients (pts) with advanced clear-cell renal cell carcinoma (accRCC) with intermediate or poor-risk disease (the TemPa trial).

Journal of Clinical Oncology2018-05-203 citations

A randomized phase II trial of pazopanib (PAZ) versus temsirolimus (TEM) in patients (pts) with advanced clear-cell renal cell carcinoma (aCCRCC) of intermediate and poor-risk (the TemPa trial).

Journal of Clinical Oncology2018-02-204 citations